Key result
Absence of Type 2 diabetes and a baseline BMI <50 kg/m2 were associated with significantly higher percent excess weight loss (MD 10.66% for non-diabetics) during mid-term follow-up (36-60 months) after Roux-en-Y gastric bypass.
Why the study?
Roux-en-Y gastric bypass has historically been the gold standard bariatric surgery, but patterns and factors associated with excess weight loss require evaluation.
What are the trends and associated factors for excess weight loss after Roux-en-Y gastric bypass in morbidly obese patients?
Cohort (n=410)
No
What are the trends and associated factors for excess weight loss after Roux-en-Y gastric bypass in morbidly obese patients?
Answers are grounded in this paper and cite their sources.
Roux-en-Y gastric bypass provides durable weight loss, but patients with baseline BMI >50 kg/m² or type 2 diabetes experience significantly less excess weight loss over 5 years.
Background Historically Roux-en-Y gastric bypass (RYGB) has been considered the gold standard of bariatric surgery. This procedure acts as a mixed restrictive and malabsorptive operation. Methods This retrospective cohort study included 410 morbidly obese patients (BMI>40kg/m² or BMI>35kg/m² along with at least one major comorbidity) who underwent primary laparoscopic RYGB surgery from 2009 to 2015 by a single surgery team. The patients were aged 18 years and older with at least 12 months follow-up with alimentary and biliopancreatic limb length of 150 and 50cm respectively. Percent excess weight loss (%EWL), Percent excess BMI loss (%EBMIL) and comorbidity resolution were compared in short-term (12 months) and mid-term (12-60 months) follow-up. Results The mean±SD age, weight, and BMI at surgery were 40.1±10.58 years, 123.32±19.88 kg, and 45.78±5.54 kg/m2, respectively, and 329 (80%) were female and 62 (15%) had T2DM. Mean±SD %EWL and %EBMIL was significantly higher in T2DM patients 9 months postoperatively and thereafter. Age at surgery, lower educational level, being single, and female patients had no significant effect on %EWL and %EBMIL during long-term follow-up. Patients with lower BMI at surgery (<50kg/m²) and non-diabetic patients had a significantly lower %EWL and %EBMIL over a short- and long-term follow-up (P<0.001). Conclusions Bariatric surgery remains the most efficacious and durable weight loss treatment. However, a proportion of patients will experience unfavorable weight loss following bariatric surgery.
No takes yet. Share an insight, caveat, or question.
Tizmaghz et al. (2022) conducted a cohort in Morbid obesity (n=410). Absence of Type 2 Diabetes Mellitus vs. Presence of Type 2 Diabetes Mellitus was evaluated on Percent excess weight loss (%EWL) during mid-term follow-up (36-60 months) (MD 10.66, 95% CI 5.6-15.7, p=<0.001). Absence of Type 2 diabetes and a baseline BMI <50 kg/m2 were associated with significantly higher percent excess weight loss (MD 10.66% for non-diabetics) during mid-term follow-up (36-60 months) after Roux-en-Y gastric bypass.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: